Erector Spinae Plane Block in Minimal Invasive Cardiac Surgery

NCT ID: NCT03825068

Last Updated: 2020-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-15

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studying the effect of erector spinae plane block in patients undergoing minimal invasive cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESP block group

patients receive ESP Bock with local anaesthetics

Group Type ACTIVE_COMPARATOR

ESP Block

Intervention Type PROCEDURE

20 ml of lacal anaesthetics will be placed below the erector spinae muscle under ultrasound guide

control group

general anaestesia

Group Type PLACEBO_COMPARATOR

general anesthetic

Intervention Type DRUG

patient receive general anaesthetic only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESP Block

20 ml of lacal anaesthetics will be placed below the erector spinae muscle under ultrasound guide

Intervention Type PROCEDURE

general anesthetic

patient receive general anaesthetic only

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective valve replacement

Exclusion Criteria

* chroic renal failure
* chronic liver failure
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rasha Hamed

lecturer of anaesthesia and pain management

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut university

Asyut, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

rasha hamed, lecturer

Role: CONTACT

01000440773

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

mohammed Ali Ahmed, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RRLL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.